Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sales, profits surge at Galliford Try

(Sharecast News) - Shares in Galliford Try sparked on Wednesday, after the construction group posted a jump in earnings amid strong trading. Revenues at the FTSE 250 firm rose 6.3% in the 12 months to 30 June, to £1.9bn, while adjusted operating profits surged 37.2% to £40.6m, ahead of expectations. The order book was nearly 8% higher at £4.1bn.

Galliford said revenues had been driven by a "robust" performance in its highways division and ongoing contracts in the water industry.

Looking to current trading, Galliford said trading momentum had continued into the new financial year, slightly ahead of expectations.

It continued: "Given the government's recently expanded commitment to the required investment in the UK's social and economic infrastructure, we see a strong pipeline of new opportunities across our chosen sectors over the next few years."

As at 0915 BST, shares in Galliford were up 6% at 456p.

Bill Hocking, chief executive, said: "Our robust risk management, balance sheet strength, professional and committed teams and strong relations with clients and suppliers enables us to successfully deliver projects and consistently add value to stakeholders.

"With 92% of projected revenue of the current financial year, and 75% of the 2027 full-year, already secured, the government's future spending plans and our aligned sector focus, we are confident in the outlook for our group."

Galliford works across a number of UK sectors. As well as water and highways, it is a key contractor in defence, custodial, education and affordable homes.

Berenberg, which has a 'buy' rating on the stock, said: "The group has delivered a fifth year of sequential growth, achieving its 2026 full-year divisional adjusted operating margin target one year early.

"Given the strong and growing order book, as well as the continued margin progress, we have increased our earnings estimates and have raised our price target from 510p to 530p."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.